John Bell is a Medical Director at AstraZeneca with over 20 years experience of working in both academia and pharma in R&D as well as Medical Affairs roles. The focus of his work is to investigate the impact that sub optimal management of respiratory disease has on the environmental impact healthcare delivery, namely the carbon burden; and to partner with healthcare systems on programmes which implement respiratory guidelines into practice. Additionally, he is part of the team at AstraZeneca team supporting the transition of its pMDI portfolio to the near zero global warming potential, next generation medical propellant, HFO-1234ze.
